← back to search

Kevin ten Haaf

Erasmus MC · NL
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Global Cancer Incidence and Screening, and Radiomics and Machine Learning in Medical Imaging.
h-index
34
citations
8,189
works
101
NIH funding
primary concept
Medicine
email

Recent publications

Eligibility and Prognostic Performance of Smoking Duration-Based Versus Pack-Year-Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups.
2026cited by 1position: contributordoi
Impact of lung cancer screening eligibility criteria on participants' characteristics and healthcare resources.
2026cited by 0position: contributordoi
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
European Journal of Cancer 2025cited by 16position: middledoi
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening.
2025cited by 9position: contributordoi
AI integrations with lung cancer screening: Considerations in developing AI in a public health setting
European Journal of Cancer 2025cited by 8position: middledoi
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling study.
2025cited by 3position: contributordoi
AI integrations with lung cancer screening: Considerations in developing AI in a public health setting.
2025cited by 3position: contributordoi
Impact of recruitment method on informed decision-making in lung cancer screening in the 4-IN-THE-LUNG-RUN trial.
2025cited by 2position: contributordoi
Towards dynamic risk assessments in lung cancer screening.
2025cited by 0position: contributordoi
Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling study.
2025cited by 0position: contributordoi
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials.
2025cited by 0position: contributordoi
Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland.
2024cited by 10position: contributordoi
Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands.
2024cited by 10position: contributordoi
The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations.
2024cited by 5position: contributordoi
Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for Australia.
2024cited by 3position: contributordoi
OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities
Journal of Thoracic Oncology 2024cited by 0position: middledoi
Considerations for Enhancing Lung Cancer Risk Prediction and Screening in Asian Populations.
2024cited by 0position: contributordoi
Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
JAMA Oncology 2023cited by 64position: middledoi
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis.
2023cited by 45position: contributordoi
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
JNCI Cancer Spectrum 2022cited by 45position: middledoi
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.
2022cited by 35position: contributordoi
Selection of eligible participants for screening for lung cancer using primary care data.
2022cited by 23position: contributordoi
Risk-based lung cancer screening eligibility criteria: towards implementation.
2022cited by 3position: contributordoi
Informing Patient Surveillance for the Growing Number of Survivors of Lung Cancer.
2022cited by 0position: contributordoi
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
2021cited by 249position: contributordoi
Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges
International Journal of Cancer 2021cited by 75position: firstdoi
Personalising lung cancer screening: An overview of risk-stratification opportunities and challenges.
2021cited by 50position: contributordoi
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
2021cited by 47position: contributordoi
Implementation of lung cancer screening: what are the main issues?
2021cited by 24position: contributordoi
Cost-effectiveness Analysis of Breast Cancer Screening Using Mammography in Singapore: A Modeling Study.
2021cited by 16position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Harry de Koning · Academic Hospital Paramaribo26 papers (2019–2025) · 12 papers (2020–2026)Rafael Meza · Laboratoire d’immunologie intégrative du cancer10 papers (2017–2024)Chung Yin Kong · Zhejiang University9 papers (2017–2023)Matthijs Oudkerk · Accelerated Ag Technologies (United States)8 papers (2017–2025)Martin C. Tammemägi · Icahn School of Medicine at Mount Sinai8 papers (2019–2026)Harry J. de Koning · The Patients Association7 papers (2017–2021)Harry J.M. Groen · University Medical Center Groningen6 papers (2017–2025)Koen de Nijs · Erasmus University Rotterdam6 papers (2023–2025)Summer S. Han · Stanford Health Care5 papers (2017–2023) · 4 papers (2020–2023)Summer S. Han · Stratford University4 papers (2020–2026)Peter M. A. van Ooijen · University Medical Center Groningen3 papers (2019–2020)Sylvia K. Plevritis · Stanford University3 papers (2017–2019)Jihyoun Jeon · ABL Bio (South Korea)3 papers (2017–2019)Eric J. Feuer · National Cancer Institute3 papers (2017–2019)David Baldwin · University of Nottingham3 papers (2020–2022)Neal D. Freedman · Division of Program Coordination Planning and Strategic Initiatives3 papers (2022–2024)Victoria Y. Ding · Palo Alto University3 papers (2022–2024) · 3 papers (2020–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Oncology →